THERIVA BIOLOGICS, INC.

Profile

Company Names

THERIVA BIOLOGICS, INC.
SYNTHETIC BIOLOGICS, INC.

Addresses

9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MD 20850

9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MD 20850

617 DETROIT STREET, SUITE 100, ANN ARBOR, MI 48108

617 DETROIT STREET,, SUITE 100, ANN ARBOR, MI 48104

Phone Numbers

301-417-4364
(301) 417-4364
(734) 332-7800

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$48,014,248.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2025-10-17 
$13,109,494.00 
$13,109,494.00 
$0.00 
 
5
2022-07-29 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
4
2022-03-10 
$1,467,502.00 
$1,467,502.00 
$0.00 
Equity 
3
2017-09-11 
$12,000,000.00 
$12,000,000.00 
$0.00 
Equity 
2
2012-10-30 
$10,800,000.00 
$10,800,000.00 
$0.00 
Equity 
1
2012-10-16 
$7,637,252.00 
$7,637,252.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
C. 
EVAN 
BALLANTYNE 
EXECUTIVE OFFICER
SYNTHETIC BIOLOGICS, INC.   |  ORCHESTRA BIOMED, INC.
STEVE 
 
KANZER 
DIRECTOR
SYNTHETIC BIOLOGICS, INC.
STEVE 
H. 
KANZER 
DIRECTOR
SYNTHETIC BIOLOGICS, INC.
JEFFREY 
 
KRAWS 
DIRECTOR
SYNTHETIC BIOLOGICS, INC.   |  SALEEN AUTOMOTIVE, INC.   |  RA MEDICAL SYSTEMS, INC.   |  SYNCROMUNE, INC.
JEFFREY 
J. 
KRAWS 
DIRECTOR
SYNTHETIC BIOLOGICS, INC.   |  THERIVA BIOLOGICS, INC.
JOHN 
 
MONAHAN 
DIRECTOR
HEAT BIOLOGICS, INC.   |  HEALTHPRIZE TECHNOLOGIES, LLC   |  SYNTHETIC BIOLOGICS, INC.   |  SCORPIUS HOLDINGS, INC.   |  THERIVA BIOLOGICS, INC.
JEFFREY 
 
RILEY 
EXECUTIVE OFFICER, DIRECTOR
SYNTHETIC BIOLOGICS, INC.   |  PERLE BIOSCIENCE, INC.   |  GAIN THERAPEUTICS, INC.   |  BLINKTBI, INC.   |  CARAVAN BIOLOGIX, INC.   |  GALENA INNOVATIONS, INC.
STEVEN 
 
SHALLCROSS 
EXECUTIVE OFFICER
CYTOMEDIX INC   |  SYNTHETIC BIOLOGICS, INC.
STEVEN 
A 
SHALLCROSS 
EXECUTIVE OFFICER, DIRECTOR
SYNTHETIC BIOLOGICS, INC.
STEVEN 
A. 
SHALLCROSS 
EXECUTIVE OFFICER, DIRECTOR
INNOCOLL HOLDINGS, INC.   |  SYNTHETIC BIOLOGICS, INC.   |  THERIVA BIOLOGICS, INC.
JOSEPH 
 
SLIMAN 
EXECUTIVE OFFICER
SYNTHETIC BIOLOGICS, INC.
SCOTT 
 
TARRIFF 
DIRECTOR
SYNTHETIC BIOLOGICS, INC.   |  ZIOPHARM ONCOLOGY INC   |  EAGLE PHARMACEUTICALS, INC.
SCOTT 
L. 
TARRIFF 
DIRECTOR
EAGLE PHARMACEUTICALS, INC.   |  SYNTHETIC BIOLOGICS, INC.
JEFFREY 
 
WOLF 
DIRECTOR
HEAT BIOLOGICS, INC.   |  GENERATIONONE, INC.   |  SYNTHETIC BIOLOGICS, INC.   |  PELICAN THERAPEUTICS, INC.
JEFFREY 
A. 
WOLF 
DIRECTOR
THERIVA BIOLOGICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-10-17 
2022-08-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-07-29 
2022-03-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-03-10 
2017-09-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-09-11 
2012-11-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-10-30 
2012-10-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-10-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
000008361
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
8361
NONE
NONE
GRIFFIN SECURITIES, INC.
43229